1,1'-Carbonyldiimidazole (CDI) Market Trends: the global market is projected to reach US$ 27.05 million

QY Research Inc. (Global Market Report Research Publisher) announces the release of 2025 latest report "1,1'-Carbonyldiimidazole (CDI)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032". Based on current situation and impact historical analysis (2020-2024) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global 1,1'-Carbonyldiimidazole (CDI) market, including market size, share, demand, industry development status, and forecasts for the next few years.

The global market for 1,1'-Carbonyldiimidazole (CDI) was estimated to be worth US$ 22.57 million in 2025 and is projected to reach US$ 27.05 million, growing at a CAGR of 3.2% from 2026 to 2032.

【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/6261479/1-1--carbonyldiimidazole--cdi

1,1'-Carbonyldiimidazole (CDI) Market Overview

Introduction
1,1'-Carbonyldiimidazole (CDI) is a versatile chemical reagent widely used as a safer alternative to phosgene. It serves as an efficient coupling and activation agent in the synthesis of amides, esters, and other carbonyl compounds. CDI is valued for its stability, reliable performance, and applicability across pharmaceutical and industrial chemical manufacturing, making it an important intermediate in fine and specialty chemicals.

Market Size and Growth
The global CDI market is projected to grow from USD 23 million in 2025 to USD 27 million by 2032, representing a CAGR of 3.2%. The market exhibits gradual growth due to its niche application in specific chemical synthesis routes, including peptide therapeutics and pharmaceutical intermediates, rather than broad commodity use.

Production Characteristics

CDI is typically produced on a campaign or make-to-order basis, rather than through large-scale stockpiling, to match the demand of specialized chemical syntheses.

Production requires stringent environmental, health, and safety (EHS) infrastructure, including toxic-gas controls, scrubbing systems, and emergency response measures.

Key Players
Major global CDI manufacturers include Lanxess, Hodogaya Chemical, Zhejiang HuTu PharmChem, and Jiangxi Jinkai Chemical. In 2025, the top three players accounted for approximately 51% of the global market share, reflecting moderate market concentration and specialization.

Market Drivers

Expansion of peptide therapeutics and peptide-based drug delivery platforms increases demand for peptide-coupling reactions, boosting CDI usage.

CDI serves as a practical and safer alternative to phosgene, supporting industry risk-reduction initiatives and compliance with stricter safety regulations.

Challenges and Restraints

High capital expenditure and specialized EHS infrastructure requirements create a significant barrier to entry for new producers.

The niche and campaign-based production model limits rapid scalability, constraining broader market expansion.

Market Opportunities

Increasing focus on safer chemical alternatives and phosgene risk mitigation drives steady adoption of CDI across pharmaceutical and fine chemical sectors.

CDI's role in advanced synthesis processes and growing applications in peptide manufacturing presents a stable, high-value niche market.

Future Outlook
The CDI market is expected to maintain steady, moderate growth due to its specialized applications and role as a safer phosgene substitute. Demand is likely to expand alongside the development of peptide therapeutics and specialty chemical intermediates, with opportunities for process innovation and efficiency improvements enhancing market competitiveness.

The report provides a detailed analysis of the market size, growth potential, and key trends for each segment. Through detailed analysis, industry players can identify profit opportunities, develop strategies for specific customer segments, and allocate resources effectively.

The 1,1'-Carbonyldiimidazole (CDI) market is segmented as below:
By Company
Lanxess
Hodogaya Chemical
Atul
GREEN Life Science
Jiangxi Jinkai Chemical
Zhejiang HuTu PharmChem
Holdenchem
Jiangsu Zhenri Chemical

Segment by Type
Purity≥98%
Purity

Segment by Application
Pharmaceuticals
Peptide Synthesis
Others

Each chapter of the report provides detailed information for readers to further understand the 1,1'-Carbonyldiimidazole (CDI) market:

Chapter 1: Introduces the report scope of the 1,1'-Carbonyldiimidazole (CDI) report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. (2021-2032)
Chapter 2: Detailed analysis of 1,1'-Carbonyldiimidazole (CDI) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc. (2021-2026)
Chapter 3: Provides the analysis of various 1,1'-Carbonyldiimidazole (CDI) market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. (2021-2032)
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.(2021-2032)
Chapter 5: Sales, revenue of 1,1'-Carbonyldiimidazole (CDI) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world..(2021-2032)
Chapter 6: Sales, revenue of 1,1'-Carbonyldiimidazole (CDI) in country level. It provides sigmate data by Type, and by Application for each country/region.(2021-2032)
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. (2021-2026)
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Benefits of purchasing QYResearch report:
Competitive Analysis: QYResearch provides in-depth 1,1'-Carbonyldiimidazole (CDI) competitive analysis, including information on key company profiles, new entrants, acquisitions, mergers, large market shear, opportunities, and challenges. These analyses provide clients with a comprehensive understanding of market conditions and competitive dynamics, enabling them to develop effective market strategies and maintain their competitive edge.

Industry Analysis: QYResearch provides 1,1'-Carbonyldiimidazole (CDI) comprehensive industry data and trend analysis, including raw material analysis, market application analysis, product type analysis, market demand analysis, market supply analysis, downstream market analysis, and supply chain analysis.

and trend analysis. These analyses help clients understand the direction of industry development and make informed business decisions.

Market Size: QYResearch provides 1,1'-Carbonyldiimidazole (CDI) market size analysis, including capacity, production, sales, production value, price, cost, and profit analysis. This data helps clients understand market size and development potential, and is an important reference for business development.

Other relevant reports of QYResearch:
1,1'-Carbonyldiimidazole(CDI)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Global 1,1'-Carbonyldiimidazole(CDI) Market Research Report 2026
Global 1,1'-Carbonyldiimidazole (CDI) Market Outlook, InDepth Analysis & Forecast to 2032
Global 1,1'-Carbonyldiimidazole (CDI) Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
Global 1,1'-Carbonyldiimidazole (CDI) Market Research Report 2026

About Us:
QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 19 years of experience and a dedicated research team, we are well placed to provide useful information and data for your business, and we have established offices in 7 countries (include United States, Germany, Switzerland, Japan, Korea, China and India) and business partners in over 30 countries. We have provided industrial information services to more than 60,000 companies in over the world.

Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
Email: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp

This release was published on openPR.